isoniazid has been researched along with 3-nitrobenzaldehyde isonicotinoylhydrazone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
de Souza, MV; Ferreira, Mde L; Henriques, Md; Lourenço, MC; Peralta, MA; Vasconcelos, TR | 1 |
Chen, MF; Coppins, R; Cynamon, MH; Davis, J; Hearn, MJ; Joo-On Kang, H; Noble, A; Terrot, MS; Thai, M; Trombino, D; Tu-Sekine, B; Webster, ER; Wilson, R | 1 |
Farias, AB; Henriques, RR; Junior, MAAL; Nogueira, TLDC; Quimas, JVF; Romeiro, NC; Santos, DC; Silva, LLD; Souza, ALF | 1 |
3 other study(ies) available for isoniazid and 3-nitrobenzaldehyde isonicotinoylhydrazone
Article | Year |
---|---|
Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
Topics: Antitubercular Agents; Hydrazines; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Spectrophotometry, Infrared | 2008 |
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.
Topics: Animals; Antitubercular Agents; Female; Isoniazid; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Structure-Activity Relationship; Tuberculosis | 2009 |
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biphenyl Compounds; Chelating Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Peroxidase; Picrates; Structure-Activity Relationship | 2020 |